Phospho-SMAD1 (Ser463/465)/ SMAD5 (Ser463/465)/ SMAD9 (Ser465/467) (D5B10) Rabbit Monoclonal…

Cell Signaling Technology Inc. was awarded a contract by the University of Virginia, a Virginia-based contracting organization, on August 8, 2026. The contract, designated A207_PO-0448451-V3, involves the supply of specialized laboratory reagents for research and diagnostic applications. The primary deliverable under this award is Phospho-SMAD1 (Ser463/465)/SMAD5 (Ser463/465)/SMAD9 (Ser465/467) (D5B10) Rabbit Monoclonal Antibody, a research-grade immunological product used in molecular biology and biomedical research applications.

The contract calls for the delivery of 373 units of the specified monoclonal antibody product at a unit price of $1.00 per unit, resulting in a total contract value of $373.00. The deliverable is designated for delivery to the buyer at the University of Virginia. While no explicit period of performance is specified in the available documentation, the award date of August 8, 2026 establishes the contract commencement date. This procurement supports the University of Virginia's research capabilities in cell signaling pathway analysis and related biomedical research activities.